Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rank in Stocks #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Share Price
$0.00023723
Last synced: 2024-08-26
Market Cap
$1.41K
Change (1 day)
111.67%
Change (1 year)
0.00%
Country
FR
Trade Pharnext S.A. (ALPHA)

Category

Dividend history for Pharnext S.A. (ALPHA)
Pharnext S.A. (stock symbol: ALPHA) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.20
Dividend yield (TTM) : 0
Dividend payments for Pharnext S.A. (ALPHA) from 2024 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR